Immuno-Oncology Summit Europe 2020
Date: March 9 - 12, 2020
Venue: Hilton London Canary Wharf, London, UK
About the postponement or cancellation of conference due to impact of the novel coronavirus infection
It may be possible that this conference will be postponed or canceled to prevent epidemic of the novel coronavirus infection. Please check up-to-date information about changes of schedule or content of the conference by visiting each organizer's website or by contacting us through inquiry page in the menu of our website.
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean

Update History
2020/02/28
Agenda,Sponsor updated
2020/01/31
Event Information updated
2020/01/27
Agenda,Speaker,Sponsor updated
2019/12/11
Agenda,Sponsor updated
2019/11/27
Sponsor updated
2019/11/18
Agenda,Speaker,Sponsor updated
2019/11/01
Sponsor updated
2019/09/30
Agenda updated
10 - 11 MARCHPreclinical and Translational Immuno-Oncology
10 - 11 MARCH Immunomodulatory Approaches
10 - 11 MARCHCARs, TILs, TCRs
11 - 12 MARCHBiomarkers for Immuno-Oncology
11 - 12 MARCH Combination Immunotherapy
11 - 12 MARCH Bispecific Antibody Design and Applications
250+
I-O
Thought Leaders
100+
Scientific Presentations
3
Days of Programming
61%
Industry
Delegates


2020 Plenary Keynote Speakers

Stanley Riddell, MD, Scientific Director, Clinical Research, Fred Hutchinson Cancer Research Center; Professor, University of Washington School of Medicine

Roy D. Baynes, MD, PhD, Senior Vice President and Head, Global Clinical Development, CMO, Merck Sharpe & Dohme


Additional 2020 Featured Speakers

Renier Brentjens, MD, PhD, Director, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center; Professor, Pharmacology, Weill Cornell Graduate School of Medical Sciences

George Coukos, Full Professor and Director, Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL); Director, Lausanne Branch, Ludwig Institute of Cancer Research Chief, Service of Immuno-Oncology, CHUV

Lindy Durrant, PhD, Professor of Cancer immunotherapy, University of Nottingham; CSO, Scancell Ltd

Gordon J. Freeman, PhD, Professor of Medicine, Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School

Maria Karasarides, PhD, Executive Director, ImmunoOncology, Regeneron Pharmaceuticals

Roland Kontermann, PhD, Professor, Biomedical Engineering, Institute of Cell Biology and Immunology, University of Stuttgart

Andrew Sewell, PhD, Distinguished Research Professor and Wellcome Trust Senior Investigator, Infection & Immunity, Cardiff University School of Medicine

Christophe-Le-Tourneau

Christophe Le Tourneau, MD, PhD, Senior Medical Oncologist, Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France

Jeanette Leusen, PhD, Associate Professor and Head Immunotherapy Group, Translational Immunology, University Medical Centre Utrecht

Wouter Scheper, PhD, Senior Postdoc, Molecular Oncology and Immunology, Netherlands Cancer Institute

Karoline Schjetne, PhD, Vice President Scientific Affairs, Vaccibody

Hans van der Vliet, MD, PhD, CSO, LAVA Therapeutics; Medical Oncologist, Amsterdam UMC

 

> VIEW ADDITIONAL ATTENDEE QUOTES

 

Attendee Breakdown


ABOUT THE EVENT

Cambridge Healthtech Institute’s Fifth Immuno-Oncology Summit Europe returns to the heart of London’s Canary Wharf for 3 days of cutting edge science and discussion. Through six conference tracks, delegates will hear from the research teams at the forefront of the rapidly developing field of cancer biotherapeutics.